Vasilios Liapis - Concepedia

Author

Vasilios Liapis

The University of Adelaide ORCID

Also Known As

V. Liapis, VASILIOS LIAPIS, Vasilios Liapis, Vasilis Liapis

Publications

833

Citations

H-Index

Concepts

All Affiliations

The University of Adelaide Basil Hetzel Institute Memorial Sloan Kettering Cancer Center Royal Adelaide Hospital Centre for Cancer Biology

About

Vasilios Liapis is an author at The University of Adelaide specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	427
2	Health Sciences	3	3	71
3	Biochemistry	3	3	65
4	Engineering	1	1	46
5	Natural Sciences	1	1	30

Vasilios Liapis

Publications

761

Citations

H-Index

Page 1

	Year	Citations
Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model Agatha Labrinidis, Shelley Hay, Vasilios Liapis, Clinical Cancer Research	2009	82
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL Lisa M. Butler, Vasilios Liapis, Stelios Bouralexis, International Journal of Cancer Breast OncologyChemoprevention StrategyHistone Deacetylase InhibitorApoptosisCell Death	2006	67
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma Vasilios Liapis, Agatha Labrinidis, Irene Zinonos, Cancer Letters Tumor BiologyMedicinePharmacologyAnti-cancer AgentCancer Treatment	2014	61
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment Vasilios Panagopoulos, Damien A. Leach, Irene Zinonos, International Journal of Oncology Breast OncologyPeroxidase TreatmentMedicineLipid PeroxidationImmunology	2017	59
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer Irene Zinonos, Agatha Labrinidis, Michelle Lee, Molecular Cancer Therapeutics	2009	50
Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: Understanding nanotoxicity by a nanomaterial model Ye Wang, Gagandeep Kaur, Aneta Zysk, Biomaterials Materials ScienceAnodic Alumina NanotubesChemical EngineeringEngineeringGreen Nanotechnology	2015	46
Apo2l/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Prevents Breast Cancer–Induced Bone Destruction in a Mouse Model Le M. Thai, Agatha Labrinidis, Shelley Hay, Cancer Research	2006	34
Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma Agatha Labrinidis, Peter Diamond, Sally K. Martin, Clinical Cancer Research	2009	32
Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells Katerina Nicolaou, Vasilios Liapis, Andreas Evdokiou, Biochemical and Biophysical Research Communications Medicinal ChemistryBromo-substituted Indirubin DerivativesChemoprevention StrategyMedicineBreast Cancer	2012	31
Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model Agatha Labrinidis, Shelley Hay, Vasilios Liapis, International Journal of Cancer Syngeneic Rat ModelBone RepairPathologyOrthopaedic SurgeryRat Model	2009	31

Page 1